Treatment for depression and other mental conditions with synthetic isotope-modified lithium
OwnerMatthew P. A. Fisherinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMatthew P. A. Fisherinventor
Estimating the term…
Treating mental illness by administering synthetic isotope-modified lithium compounds: (i) with the lithium-6 isotope making up at least 95% of the total number of lithium atoms in the compound to treat depression and other mental conditions with reduced alertness levels, (ii) with the lithium-7 isotope making up at least 95% of the total number of lithium atoms in the compound to treat mania and bipolar disorder and other mental illnesses which respond to lithium compounds with natural isotope abundance levels, (iii) with the lithium-6 isotope ranging from 10% to 95% of the total number of lithium atoms in the compound individually tailored to treat patients with a broad variety of mental disorders, including those in (i) and (ii) above
A method for treating mental conditions, comprising administering a synthetic isotope-modified lithium-compound containing lithium-6 isotopes in an amount of at least 95% of a total number of lithium atoms in the compound, at dosages of about 100 mg/day to 1500 mg/day, whereby a symptom of the mental condition is alleviated.
A method of treating mental conditions comprising administering a synthetic isotope-modified lithium-compound containing lithium-7 isotopes in an amount of at least 95% of a total number of lithium atoms in the compound, at dosages of 200 mg/day to 1200 mg/day, whereby a symptom of the mental condition is alleviated.
A method of treating mental conditions by administering a synthetic isotope-modified lithium-compound containing lithium-6 isotopes in an amount ranging from 10% to 95% of a total number of lithium atoms in the compound, wherein the compound is administered at dosages ranging from 100 mg/day to 1500 mg/day, whereby a symptom of the mental condition is alleviated.
Dependencies are inferred from the claim text.